The Continuation Fund: How a GP Sells an Asset to a Vehicle It Also Manages — and Why It Now Sits on Both Sides of Every Trophy-Asset Exit

A Continuation Fund Is a GP Selling an Asset to a Vehicle It Also Manages

A continuation fund is a new investment vehicle a private equity manager raises for a single purpose: to buy one or more portfolio companies out of one of its own older funds, so it can continue to own them past that fund’s expiry. The money to make the purchase comes from fresh investors — secondary buyers writing new cheques — and, usually, from existing investors who choose to roll their stakes across. The asset changes vehicle; the manager does not change. The same GP that bought the company, ran it and is now selling it is also the one buying it. That single fact — a manager transacting with itself — is what defines the structure and what makes it contentious.

It is the headline example of a GP-led secondary, and the distinction from the older, better-known kind of secondary matters. In a traditional LP-led secondary, an investor that wants out of a fund early sells its stake to a secondary buyer; the GP is a bystander to a trade between two LPs. In a GP-led secondary the manager initiates the transaction, chooses which assets move and structures the vehicle they move into. The GP has gone from spectator to author of the deal — and, in a continuation fund, from author to counterparty.

How the Transaction Works: New Vehicle, Fresh Capital, Old Asset

The mechanics are more orderly than the concept sounds. A closed-end buyout fund typically has a ten-year life, often stretched to twelve or thirteen with extensions. As that clock runs down, the GP identifies an asset it does not want to sell — usually because it is still compounding and a forced exit would leave return on the table. Rather than run a dual-track sale or IPO, it sets up a continuation vehicle and appoints a secondary investor — or a syndicate of them — to lead the pricing and anchor the new capital. That lead investor negotiates a price for the asset, and the old fund sells at that price into the new one.

The proceeds flow back to the original fund’s LPs, who now face the choice the structure exists to give them. The new vehicle holds the single asset (a single-asset continuation fund) or a handful of them (a multi-asset one), typically with a fresh three-to-five-year life, a new management fee and a reset carry. The GP runs it exactly as it ran the company before, only with a longer runway and a new set of economics. In effect the asset is realised on paper and re-acquired in the same breath, without ever leaving the manager’s control.

Why a GP Does It: A Trophy Asset the Fund Clock Won’t Let It Keep

The honest reason a manager builds a continuation fund is that the fund’s life has run out before the asset’s value has. A ten-year fund that bought a company in year five is structurally forced to sell it in years eight-to-ten, regardless of whether that is the right moment. If the company is still growing double digits and the GP believes another three years compounds meaningfully more value, selling to a third party hands that upside to the buyer. The continuation fund lets the manager keep the asset — and the upside — while still returning capital to the LPs who want it.

That is the legitimate case, and it is a real one. The problem is that the same structure serves a less flattering purpose equally well. A continuation fund also generates a fresh management-fee stream and a reset carry on an asset the GP already owns, and it lets a manager show a realisation — DPI, distributed capital — in a fund it is trying to wind down or raise a successor to. When a GP that is fundraising moves its best asset into a continuation vehicle at a price it set, an LP is entitled to ask whether the deal is being done for the company’s future or the manager’s. Both motives wear the same clothes, which is precisely why the price test matters so much.

The Three Choices Every Existing LP Faces

What makes a continuation fund different from every other exit is that it does not simply return cash — it forces the original LPs to make a decision. When the transaction closes, each existing investor is offered a menu, and the choice it makes determines whether it treats the deal as an exit or a re-underwriting.

The status-quo option is the one that separates a well-run process from a coercive one. Without it, a rolling LP is quietly moved onto worse economics than it had, and the “choice” becomes cash out or pay more to keep what you already owned. The presence of a genuine status-quo alternative is one of the first things a diligent LP looks for.

The Conflict at the Centre: The GP Sets the Price on Both Sides

Strip away the machinery and a continuation fund is a manager selling an asset from a fund it controls to a fund it controls, at a price it is heavily involved in setting. In an arm’s-length sale the buyer’s self-interest disciplines the price — a third party pays as little as it can. Here the buyer is, in economic substance, the same house as the seller. The GP has an incentive to keep the entry price into the continuation fund low, which helps the new investors it must now satisfy and inflates the reset carry — and that incentive runs directly against the selling LPs, who want the highest possible exit price. No other exit route contains this contradiction.

How the Price Gets Tested: The Fairness Opinion, the LPAC and a Marketed Process

Because the conflict is unavoidable, the defence is procedural: the deal has to demonstrate that the price was tested by someone other than the GP. Three checks do most of that work. A fairness opinion from an independent adviser states that the price sits within a defensible valuation range — necessary, but weak on its own, since a range can be built wide enough to bless almost any number. Approval from the fund’s LPAC, the LP advisory committee that exists to sign off on conflicts, is the second. The strongest is the third: a genuinely competitive process, where the lead secondary investor’s price is set through real negotiation or a market check rather than agreed quietly with a favoured buyer.

Industry guidance has hardened around exactly these points. The main LP trade body issued detailed continuation-fund guidance in 2023 that pushes GPs to run the process to maximise price for the exiting LPs, to disclose conflicts fully, and to offer that genuine status-quo roll option. None of it removes the conflict — nothing can, short of the GP not transacting with itself — but it raises the cost of pricing an asset cheaply to oneself, and it gives LPs a checklist to hold a manager to.

Crystallised Carry, Reset Economics: Why the GP’s Cheque Changes Shape

The economics are the least understood part of the structure and the part that most exposes the GP’s incentives. When the old fund sells the asset, the GP crystallises its carried interest on the gain — the deal is a realisation, so carry that had only accrued on paper is now earned and, in most structures, at least partly paid. That is a genuine payday, and it is one the GP would not see for years if it simply held the asset in the old fund. Right there is a reason to prefer a continuation fund to patience, independent of what is best for the company.

Then the meter resets. The continuation vehicle carries a new management fee and a fresh carry with its own hurdle, struck against the transaction price as the new cost basis. The GP earns carry twice on the same company — once on the gain to the old fund, then again on any gain from the continuation-fund entry price onward. A low entry price serves that second layer: the lower the reset basis, the more of the asset’s future value falls into the new carry. This is the mechanical version of the pricing conflict, and it is why the entry price is never a neutral number to the manager setting it. For the fund-economics backdrop — how carry, fees and the GP actually makes money — the same logic runs underneath.

Why the Market Exploded — and Why LPs Stayed Wary

The continuation fund went from fringe to mainstream in about five years, and the timing explains the suspicion around it. Through the higher-rate, slower-exit environment that set in from 2022, traditional exits dried up — IPO windows shut, and strategic and sponsor buyers pulled back on price. GPs sitting on maturing funds full of assets they could not sell at acceptable valuations, and LPs starved of distributions, both needed liquidity. The continuation fund manufactured it: a way to return capital to the LPs who wanted out and hold the asset for those who did not, without crossing a reluctant open market. GP-led volume climbed to roughly $70bn in 2024 and kept setting records into 2025 — approximate figures, but the direction is not in doubt.

LP wariness is the counterweight, and it is rational. The structure was born, in its earlier life, as a place to park assets a GP could not sell — which is precisely the association it has spent the last few years trying to shed. When distributions are scarce and a manager is raising its next fund, an LP has every reason to suspect a continuation fund is being used to flatter a track record or generate fees rather than to compound a genuine winner. The tell, again, is the price and the process: a competitively priced deal with a real status-quo option reads as conviction; a quietly priced one with a coercive roll reads as financial engineering. LPs have learned to tell the two apart, and the good GPs have learned to give them the evidence.

How This Shows Up in a PE Interview

Continuation funds have become a live interview topic precisely because they are where modern private equity’s tensions concentrate. The direct question — “what is a continuation fund?” — wants the mechanic: a new GP-managed vehicle buys an asset out of an older fund of the same manager, funded by fresh secondary capital, giving existing LPs the choice to cash out or roll. The sharper question is the judgement one — “what is the problem with them?” — and a strong answer goes straight to the conflict: the GP sets the price on both sides, so the entire integrity of the deal rests on whether that price was independently tested through a fairness opinion, LPAC approval and a genuinely marketed process. Name the conflict and name the checks, and you have said what most candidates miss.

Take Your Preparation Further

A continuation fund is one route out of an asset; for the others and how a GP chooses between them, read how private equity exits a deal and the dual-track IPO-versus-sale process. For the fund economics the structure resets — fees, carry and hurdles — see how private equity firms make money and the carried interest waterfall. For a related liquidity tool GPs reach for in the same distribution-starved market, read NAV financing.

To keep the valuation methods that anchor a fairness opinion at your fingertips, download the free Valuation Methods Cheat Sheet, and for the fund-structure and conflict questions a PE interview builds toward, work through the PE Interview Masterclass.

Ready for personalised feedback? Book a 1-on-1 mentoring session with an experienced IB/PE professional.